CURRICULUM VITAE
Paula A. Rochon, MD, MPH, FRCPC
Date of most recent revision: 15-Feb-16
PUBLICATIONS
Peer Reviewed Journals
1.
Millard PH, Higgs P, Rochon P. Aging: Should it be left to chance? BMJ 1989; 298:1020-1021
(Collaborator).
2.
Rochon PA, Fortin PR, Dear KBG, Minaker KL, Chalmers TC. Reporting of Age Data in Clinical
Trials of Arthritis: Deficiencies and Solutions. Arch Intern Med. 1993;153:243-248 (Principal
Author).
3.
Rochon PA, Minaker KL. Agency for Health Care Policy and Research Guidelines for Pressure
Ulcer Prevention: Improving Practice and a Stimulus for Research. Journal of Gerontology:
Medical Sciences. 1993;48(1):M3-M5 (Principal Author).
4.
Rochon PA, McGlinchey-Berroth R, Beaudet MP, Morrow L, Ahlquist M, Young R, Minaker KL.
Risk Assessment for Pressure Ulcers: An Adaptation of the National Pressure Ulcer Advisory
Panel Risk Factors for Spinal-Cord Injured Patients. The Journal of the American Paraplegia
Society. 1993;16:166-174 (Principal Author).
5.
Rochon PA, Gurwitz JH, Simms RW, Fortin PR, Felson DT, Minaker KL, Chalmers TC. A Study
of Manufacturer Supported Trials of Nonsteroidal Anti-inflammatory Drugs in the Treatment of
Arthritis. Arch Intern Med. 1994;154:157-163 (Principal Author).
6.
Rochon PA, Gurwitz JH, Cheung CM, Hayes JA, Chalmers TC. Evaluating the Quality of Articles
Published in Journal Supplements Compared with the Quality of those Published in the Parent
Journal. JAMA. 1994;272:108-113 (Principal Author).
7.
Rochon PA, Gurwitz JH. Drug Therapy. The Lancet. 1995;346:32-36. (Senior Responsible
Author).
8.
Dickinson E, Rochon PA, Cochrane Collaboration in Health Care of Elderly People, Age and
Aging. 1995;24:265-266 (Collaborator).
9.
Rochon PA, Katz J., McGlinchey-Berroth R, Ahlquist M, Morrow L, Sarkarati M, Minaker KL. Comorbid Illness is Associated with Survival and Length of Hospital Stay in Patients with Chronic
Disability: A Prospective Comparison of Three Co-Morbidity Indices. Medical Care.
1996;34(11):1093-1101 (Principal Author).
10.
Rochon PA, Gurwitz JH. Geriatrics Update 1996: The Age of Women, The Lancet.
1996;348(suppl II):8. (Principal Author).
11.
Rochon PA (Guest Editor for the BMJ Aging Theme Issue), Smith Richard. Aging: a global
theme issue. BMJ 1996;313:1502 (editorial) . (Co-Principal Author).
12.
Rochon PA, Dickinson E, Gordon M. The Cochrane Field in Health Care of Older People:
Geriatric Medicine’s Role in the Collaboration. Journal of the American Geriatrics Society.
1997;45(2):241-243 (Principal Author).
13.
Rochon PA, Gill S, Litner J, Fischbach M, Goodison A, Gordon M. A Systematic Review of the
Evidence for Hypodermoclysis to Treat Dehydration in Older People. The Journals of
Gerontology: Medical Sciences. 1997;52A(3):M169-176 (Principal Author).
14.
Gurwitz JH, Monnette J, Rochon PA, Eckler MA, Avorn J. Atrial Fibrillation and Stroke
Prevention with Warfarin in the Long-Term Care Setting. Arch Intern Med. 1997;157:978-984
(Collaborator).
February 15, 2016
1
CURRICULUM VITAE
Paula A. Rochon, MD, MPH, FRCPC
15.
Gurwitz JH, Rochon PA, Avorn J. Optimizing Drug Therapy in the Elderly. Pharmacy &
Therapeutics. 1997;22(7):331-347 (Collaborator).
16.
Monnette J, Gurwitz JH, Rochon PA, Avorn J. Physician Attitudes Concerning Warfarin for
Stroke Prevention in Atrial Fibrillation: Results of a Survey of Long-Term Care Practitioners. J Am
Geriatr Soc 1997;45:1060-1065 (Collaborator).
17.
Greengross S, Murphy E, Quam L, Rochon PA, and Smith R (Editors for BMJ Aging Issue).
October 1997. Aging: a subject that must be at the top of world agendas. British Medical
Journal. 1997;315:1029-30 (editorial). Article reprinted in the Student British Medical Journal.
1997:5;398-399 (Collaborator).
18.
Rochon PA, Gurwitz JH. Optimizing drug treatment for elderly people: The Prescribing Cascade.
BMJ 1997;315:1096-1099. (Principal Author).
19.
Rochon PA, Oxman T. Global Theme Issue on Aging. International Journal of Psychiatry in
Medicine. 1997;27(3):181-184 (editorial). (Principal Author).
20.
Clark JP, Dasgupta M, Rochon PA. Optimizing Prescribing for Older Women: A Program to
Evaluate the Benefits of Low Dose Cardiovascular Medications. Mature Medicine Canada.
1998;1(3):28-31. (Senior Responsible Author).
21.
Alibhai SMH, Rochon PA. The Controversy Surrounding Cholesterol Treatment in Older People.
Geriatric Nephrology and Urology. 1998;8:11-14. (Senior Responsible Author).
22.
Rochon PA, Clark JP, Binns MA, Patel V, Gurwitz JH. Reporting of Gender-related Information
in Clinical Trials of Drug Therapy for Myocardial Infarction. CMAJ 1998;159(4):321-327 (Principal
Author).
23.
Rochon PA, Berger P, Gordon M. Evolution of clinical trials: inclusion and representation CMAJ
1998;159(11):1373-1374 (editorial). (Principal Author).
24.
Rochon PA, Binns MA, Litner JA, Fischbach MS, Eisenberg D, Kaptchuk TJ, Stason WB,
Chalmers TC. Are Randomized Control Trial Outcomes Influenced by the inclusion of a Placebo
Group? A systematic review of nonsteroidal anti-inflammatory drug trials for arthritis treatments.
Journal of Clinical Epidemiology. 1999;52(2):113-122 (Principal Author).
25.
Rochon PA, Clark JP, Gurwitz JH. Challenges of Prescribing Low Dose Drug Therapy for Older
People. CMAJ 1999;160:1029-31 (Principal Author).
26.
Rochon PA, Gurwitz JH. Prescribing for Seniors: Neither too much nor too little? JAMA
Contempo 1999. 1999;282:113-115 (Principal Author).
27.
Rochon PA, Anderson G, Tu J, Gurwitz JH, Clark JP, Shear NH, Lau P. Age and GenderRelated use of Low Dose Drug Therapy: The Need to Manufacture ‘Seniors’ Doses’ and to
Evaluate the Minimum Effective Dosage. Journal of the American Geriatrics Society.
1999;47:954-959 (Principal Author).
28.
Bressler H, Keyes WJ, Rochon PA, Badley E. The Prevalance of low back pain in the elderly: A
systematic review of the literature. Spine 1999;24:1813-1819 (Collaborator).
29.
Rochon PA, Anderson GM, Tu JV, Clark JP, Gurwitz JH, Szalai JP, Lau P. Use of -blocker
therapy in older patients after acute myocardial infarction in Ontario. CMAJ 1999; 161:1403-1408
(Principal Author).
30.
Gurwitz, JH, Rochon PA. Health Care Quality, the Elderly Patient, and the Primary Care
Physician. Journal of the American Geriatrics Society. 1999;47:1473-1474 (Collaborator).
February 15, 2016
2
CURRICULUM VITAE
Paula A. Rochon, MD, MPH, FRCPC
31.
Gurwitz JH, Rochon PA. Considerations in Designing an Ideal Medication-use System: Lessons
from Caring for the Elderly. American Journal of Health-System Pharmacy. 2000;157:548-551.
(Collaborator).
32.
Dasgupta M, Binns M, Rochon PA. Subcutaneous fluid infusion in Long-Term Care Setting.
Journal of the American Geriatrics Society. 2000;48:795-799 (Senior Responsible Author).
33.
*
34.
Gold J, Laxer D, Rochon PA. Herbal Remedies: A Critical Perspective. Annals RCPSC.
2000;33:497 (Senior Responsible Author).
35.
Gold J, Laxer D, Dergal J, Lancot K, Rochon PA. Herbal drug therapy interactions: A focus on
dementia. Current Opinion in Clinical Nutrition and Metabolic Care. 2001;4(1):29-34. (Senior
Responsible Author).
36.
Fischbach M, Gold J, Lee M, Dergal J, Litner G, Rochon PA. Pill Splitting in a Long-Term Care
Facility. CMAJ 2001;164(5):785-786 (Senior Responsible Author).
37.
Gill SS, Dasgupta M, Rochon PA. Hypodermoclysis in the treatment of dehydration. American
Family Physician 2001;64(9):1516-1519 [editorial]. (Senior Responsible Author)
38.
Pryse-Phillips W, Sternberg S, Rochon PA, Naglie G, Strong H, Feightner J. The Use of
Medications for Cognitive Enhancement. The Canadian Journal of Neurological Sciences.
2001;28:Suppl 1-S108-S114. (Collaborator)
39.
Etminan M, Samii A,Takkouche B, Rochon PA. Increased risk of somnolence with the new
dopamine agonists in patients with Parkinson’s disease: A meta-analysis of randomised
controlled trials. Drug Safety. 2001;24(11):863-868. (Senior Responsible Author).
40.
Takkouche B, Etminan M, Camao P, Rochon PA. Interaction between aspirin and ACE Inhibitors:
Resolving discrepancies using a meta-analysis. Drug Safety 2002;25(5):373-8 (Senior
Responsible Author).
41.
Etminan M, Levine MAH, Tomlinson G, Rochon PA. Efficacy of Angiotensin II receptor
antagonists in preventing headache: A Systematic overview and meta-analysis. American Journal
of Medicine 2002;112:642-646. (Senior Responsible Author).
42.
*
43.
Clark JP, Feldberg GD, Rochon PA. Representation of women's health in general medical
versus women's health specialty journals: A content analysis. BMC Women’s Health. 2002,2:5
(Senior Responsible Author).
44.
Gurwitz JH, Rochon, P.A. Improving the Quality of medication use in the Elderly: A not-so-simple
prescription. Arch Intern Med. 2002;162:1670-1673. (Collaborator)
45.
Mamdani M, Rochon PA, Juurlink DN, Austin P, Kopp A, Anderson GM, Naglie G, Austin PC,
Laupacis A. Observational study of upper gastrointestinal haemorrhage in elderly patients given
selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs. BMJ
2002;325:624. (Collaborator)
46.
Mamdani M, Rochon PA, Laupacis A, Anderson G. Initial patterns of use of COX-2 inhibitors by
elderly patients in Ontario: Findings and implications. CMAJ. 2002;167(10).
(http://www.cmaj.ca/cgi/content/full/167/10/1125). (Collaborator)
Rochon PA, Tu JV, Anderson GM, Gurwitz JH, Clark JP, Lau P, Szalai JP, Sykora K, Naylor
CD. Rate of heart failure and 1-year survival for older people receiving low-dose ß-blocker
therapy after myocardial infarction. The Lancet. 2000;356:639-644. (Principal Author).
Rochon PA, Bero LA, Bay AM, Gold JL, Dergal JM, Binns MA, Streiner DL, Gurwitz JH.
Comparison of Review Articles Published in Peer-Reviewed and Throwaway Journals. JAMA
2002;287:2853-2856. (Principal Author).
February 15, 2016
3
CURRICULUM VITAE
Paula A. Rochon, MD, MPH, FRCPC
47.
Dergal JM, Gold HL, Laxer DA, Lee MSW, Binns MA, Freedman M, Rochon PA. Potential
interactions between herbal medicines and conventional drug therapies used by older adults
attending a memory clinic. Drugs & Aging. 2002;19(11):879-886. (Senior Responsible Author)
48.
Marras C, Rochon PA, Lang AE. Predicting motor decline and disability in Parkinson’s disease: A
systematic review. Archives of Neurology. 2002;59:1724-1728. (Collaborator)
49.
Hall SF, Rochon PA, Streiner DL, Paszat LF, Groome PA, Rohland SL. Measuring comorbidity
in patients with head and neck cancer. Laryngoscope. 2002;112:1988-1996. (Collaborator)
50.
Dhalla IA, Anderson GM, Mamdani MM, Bronskill SE, Sykora K, Rochon PA. Inappropriate
prescribing before and after nursing home admission. Journal of the American Geriatrics Society
2002;50(6):995-1000. (Senior Responsible Author)
51.
Gill SS, Rochon PA, Guttman M, Laupacis A. The value of positron emission tomography in the
clinical evaluation of dementia. Journal of the American Geriatrics Society. 2003;51:258-264.
(Collaborator)
52.
Mamdani M, Rochon PA, Juurlink DN, Anderson GM, Kopp A, Naglie IG, Austin PC, Laupacis A.
Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-term risk of acute
myocardial infarction in the elderly. Arch Intern Med. 2003;163:481-6. (Collaborator)
53.
Shulman KI, Rochon PA, Sykora K, Anderson GM, Mamdani M, Bronskill S, Tran CTT. Changing
prescription patterns for lithium and divalproex in old age: shifting practice without evidence. BMJ
2003;326. Issue 7396. (Senior Responsible Author)
54.
Gold JL, Laxer MS, Rochon PA. Monitoring Contracts with Industry: Why Research Ethics
Boards Must be Involved. Health Law Review. Volume 11, No. 3, 2003. (Senior Responsible
Author)
55.
Etminan M, Streiner DL, Rochon PA. Exploring the association between atypical neuroleptic
agents and diabetes mellitus in older adults. Pharmacotherapy 2003; 23(11):1411-1415. (Senior
Responsible Author)
56.
Juurlink D, Mamdani M, Rochon PA, Kopp A, Shulman K, Redelmeier D. Drug-induced lithium
toxicity in the elderly: A population-based study. J Am Geriatr Soc May 2004;52(5):794-8.
(Collaborator)
57.
* Rochon PA, Mashari A, Cohen A, Misra A, Laxer D, Streiner DL, Dergal JM, Clark JP, Binns
MA. The relation between randomized controlled trials published in leading general medical
journals and the global burden of disease. CMAJ May 25, 2004; 170(11): 1673-77. (Principal
Author)
58.
Bronskill SE, Anderson GM, Sykora K, Wodchis W, Gill S, Shulman KI, Rochon PA. Neuroleptic
Drug Therapy in Older Adults newly admitted to nursing homes: Incidence, Dose and Specialist
Contact. J Am Geriatr Soc May 2004. 52: 749-755. (Senior Responsible Author)
59.
Mamdani M, Juurlink DN, Lee DS, Rochon PA, Kopp A, Naglie G, Austin PC, Laupacis A, Stukel
TA. Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and
congestive heart failure outcomes in elderly patients: a population-based cohort study. The
Lancet, May 2004;363:1751-1756. (Collaborator)
60.
Fitchett D, Rockwood, K, Chan BTB, Shultz S, Bogaty P, Gillis A, Arnold M, Miller, F, Graham
MM, Ghali WA, Cartier R, Chow CM, Grymonpre R, Ogilvie R, Rochon PA, Niznick J, Grover S,
Kavanah T, Triscott J, Dafoe W, McCartney N, Rodney P, Howlett J. Canadian Cardiovascular
Society Consensus Conference 2002: Management of heart disease in the elderly patient.
Canadian Journal of Cardiology 2004;20(Suppl A):7A-16A. (Collaborator)
February 15, 2016
4
CURRICULUM VITAE
Paula A. Rochon, MD, MPH, FRCPC
61.
Rochon PA, Sykora K, Bronskill SE, Mamdani M, Anderson GM, Gurwitz JH, Gill S, Tu JV,
Laupacis A. Use of Angiotensin-converting Enzyme Inhibitor Therapy and Dose-related
Outcomes in Older Adults with New Heart Failure in the Community. Journal of General Internal
Medicine 2004 June;19(6):676-83. (Principal Author)
62.
Lee PE, Gill SS, Freedman M, Bronskill SE, Hillmer MP, Rochon PA. Atypical Antipsychotic
drugs in the treatment of behavioural and psychological symptoms of dementia: Systematic
review. BMJ 2004 Jul 10;329(7457):75-78. (Senior Responsible Author)
This BMJ article was selected for abstraction in ACP Journal Club, a bi-monthly publication of the American
College of Physicians. It was also reviewed by Pierre N Tariod, MD, in Evidence-Based Mental Health,
ebmh5012, Module 32, 6/12/04 17 :32 :31.
63.
Lane CJ, Bronskill SE, Sykora K, Dhalla IA, Anderson GM, Mamdani MM, Gill SS, Gurwitz JH,
Rochon PA. Potentially Inappropriate Prescribing in Ontario Community-dwelling Older Adults
and Nursing Home Residents. J Am Geriatr Soc 2004 Jun;52(6):861-6. (Senior Responsible
Author)
64.
Etminan M, Carleton B, Rochon PA. Quantifying Adverse Drug Events: Are Systematic Reviews
the Answer? Drug Safety, August 2004:27(11): 757-761. (Senior Responsible Author)
65.
Rochon PA, Lane C, Bronskill SE, Sykora K, Anderson GM, Mamdani M, Gurwitz JH, Dhalla I.
Potentially Inappropriate Prescribing in Canada Relative to the US. Drugs and Aging
2004:21(14):939-947. (Principal Author)
66.
Gill SS, Bronskill SE, Mamdani M, Sykora K, Li P, Shulman KI, Anderson GM, Hillmer MP,
Wodchis WP, Rochon PA. Representation of Patients with Dementia in Clinical Trials of
Donepezil. Can J Clin Pharmacol. 2004 Fall;11(2):e274-e285. (Senior Responsible Author)
67.
Rochon PA, Mashari A, Cohen A, Misra A, Laxer D, Streiner DL, Clark JP, Dergal JM, Gold J.
The inclusion of minority groups in clinical trials: Problems of under-representation and underreporting of data. Accountability in Research 2004 Jul-Dec;11(3-4):215-23. (Principal Author)
68.
Marras C, McDermott MP, Rochon PA, Tanner CM, Naglie G, Rudolph A, Lang AE. Survival in
Parkinson’s disease: Thirteen year follow-up of the DATATOP cohort. Neurology 2005; 64:87-93.
(Collaborator)
69.
Hillmer MP, Wodchis WP, Gill SS, Anderson GM, Rochon PA. Nursing Home Profit Status and
Quality of Care: is there any evidence of an association? Medical Care Research and Review,
Vol. 62 No. 2, (April 2005) 139-166. (Senior Responsible Author)
70.
Wodchis W, Teare G, Naglie G, Bronskill SE, Gill SS, Hillmer MP, Anderson GM, Rochon PA,
Fries BE. Skilled Nursing Facility Rehabilitation and Discharge to Home after Stroke. Archives of
Physical Medicine and Rehabilitation 2005;86(3):442-448. (Collaborator)
71.
Herrmann N, Gill SS, Bell C, Andersom GM, Bronskill SE, Shulman KI, Fischer H, Sykora K, Shi
HS, Rochon PA. Incidence of Delerium in Older Adults Newly Prescribed Lithium or Valproate: A
population-based cohort study. J Clin Psychiatry 2005;66:424-427. (Senior Responsible Author)
72.
Shulman KI, Sykora K, Gill SS, Mamdani M, Anderson GM, Marras C, Wodchis WP, Lee PE,
Rochon PA. New thyroxine treatment in older adults beginning lithium therapy: implications for
clinical practice. The American Journal of Geriatric Psychiatry 2005;13(4):299-304. (Senior
Responsible Author)
73.
Gurwitz JH, Field TS, Judge J, Rochon PA, Harrold LR, Cadoret C, Lee M, White K, LaPrino J,
Erramuspe-Mainar J, DeFlorio M, Gavendo L, Auger J, Bates DW. The Incidence of Adverse
Drug Events in Two Large Academic Long-Term Care Facilities: Higher than expected? The
American Journal of Medicine 2005;118:251-258. (Collaborator)
February 15, 2016
5
CURRICULUM VITAE
74.
Paula A. Rochon, MD, MPH, FRCPC
Gill SS, Rochon PA, Herrmann N, Lee PE, Sykora K, Gunraj N, Normand SLT, Gurwitz JH,
Marras C, Wodchis WP, Mamdani M. Atypical Antipsychotic Drugs and Risk of Ischemic Stroke:
Population Based Retrospective Cohort Study. BMJ. 2005 Feb 26;330(7489):445 (Collaborator)
This BMJ paper was abstracted by the American Association of Geriatric Psychiatry. It was also awarded a
Canadian Institutes of Health Research (CIHR) Institute of Aging “AgePlus” prize.
75.
Gill SS, Mamdani M, Naglie G, Streiner DL, Bronskill SE, Kopp, A, Shulman KI, Lee PE, Rochon
PA. A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs. Arch
Intern Med. 2005 Apr 11;165(7):808-13. (Senior Responsible Author)
76.
* Rochon PA, Gurwitz JH, Sykora K, Mamdani MM, Streiner DL, Garfinkel S, Normand SL,
Anderson GM. Readers Guide to Critical Appraisal of Cohort Studies: 1 .Role and Design. BMJ
2005;330:895-7. (Principal Author)
77.
Mamdani MM, Sykora K, Li P, Normand SLT, Streiner DL, Austin PC, Rochon PA, Anderson GM.
Readers Guide to Critical Appraisal of Cohort Studies: 2. Assessing Potential for Confounding.
BMJ 2005;330:960-2. (Collaborator)
78.
Normand SLT, Sykora K, Li P, Mamdani MM, Rochon PA, Anderson GM. Readers Guide to
Critical Appraisal of Cohort Studies: 3. Analytical Strategies to Reduce Confounding. BMJ
2005;330:1021-23. (Collaborator)
79.
Rapoport M, Mamdani M, Shulman K, Herrmann N, Rochon PA. Antipsychotic use in the elderly:
shifting trends and increasing costs. Int J Geriatr Psychiatry 2005 Jul 21;20(8):749-753. (Senior
Responsible Author)
80.
Lee PE, Sykora K, Gill SS, Mamdani M, Marras C, Anderson GM, Shulman K, Stukel T, Normand
SL, Rochon PA. Antipsychotic Medications and Drug Induced Movement Disorders other than
Parkinsonism: A population-based cohort study in older adults. J Am Geriatr Soc 53:1374-1379,
2005. (Senior Responsible Author)
81.
Rochon PA, Field TS, Bates DW, Lee M, Gavendo L, Judge J, Gurwitz JH. Computerized
Physician Order Entry with Clinical Decision Support in the Long-term care Setting: Insights from
the Baycrest Centre for Geriatric Care. J Am Geriatr Soc 53:1780-1789, 2005. (Principal Author)
82.
* Rochon PA, Stukel TA, Sykora K, Gill SS, Garfinkel S, Anderson GM, Normand SLT, Mamdani
MM, Lee PE, Li P, Bronskill SE, Marras C, Gurwitz JH. Atypical Antipsychotics and Parkinsonism.
Arch Intern Med. (September 12) 2005; 165:1882-1888. (Principal Author)
Cited as a PRACTICE POINT in Nature Clinical Practice Neurology (London, UK) 2006. Vol
2(3):132-133.
83.
Rochon PA, Field TS, Bates DW, Lee M. Gavendo L, Erramuspe-Mainard J, Judge J, Gurwitz
JH. Clinical application of a computerized system for physician order entry with clinical decision
support to prevent adverse drug events in long-term care. CMAJ 2006 Jan 3;174(1):52-54.
(Principal Author)
84.
Ngai S, Gold JL, Gill SS, Rochon PA. Haunted Manuscripts: Ghost Authorship in the Medical
Literature. Accountability in Research, 2005;12:103-114. (Senior Responsible Author)
85.
Mamdani M, Rapoport M, Shulman KI, Herrmann N, Rochon PA. Mental Health-Related Drug
Utilization Among Older Adults: Prevalence, Trends, and Costs. Am J Geriatr Psychiatry
2005;13:892-900. (Collaborator)
86.
Gold JL, Shulman TJ, Rochon PA. Public Reporting on Quality of Long-Term Care Homes in
Ontario. Geriatrics and Aging, 2006 January; 9(1):49-52.
February 15, 2016
6
CURRICULUM VITAE
Paula A. Rochon, MD, MPH, FRCPC
87.
Sharma P, Herrmann N, Rochon PA, Lee M, Croxford R, Rothenburg L, Black SE, Lanctôt KL.
Perceptions of Natural health Products Among Patients Attending a Memory Clinic. American
Journal of Alzheimer’s Disease & Other Dementias. 2006 Jun/Jul;21(3):156-163. (Collaborator)
88.
Zadikoff C, Rochon P, Lang A. Cardiac Valvulopathy Associated with Pergolide Use. Canadian
Journal of Neurological Sciences February 2006. Can J Neurol Sci 2006;33:27-33 (Collaborator)
89.
Gagnier JJ, Boon H, Rochon PA, Barnes J, Moher D, Bombardier CB for the CONSORT Group.
Recommendations for reporting randomized controlled trials of herbal interventions: an
elaborated CONSORT statement. Ann Int Med 2006;144:364-367. (Collaborator)
90.
Gagnier JJ, Boon H. Rochon PA, Barnes J, Moher D, Bombardier CB for the CONSORT Group.
Recommendations for reporting randomized controlled trials of herbal interventions: Explanation
and elaboration. J Clin Epidemiol 2006 Nov;59(11):1134-49. (Collaborator)
91.
Hall SF, Groome PA, Streiner DL, Rochon PA. Interrater reliability of measurements of comorbid
illness should be reported. J Clin Epidemiol. 2006 Sep;59(9):926-933. (Senior Responsible
Author)
92.
Gagnier JJ, DeMelo, Boon H, Rochon PA, Bombardier CB. Quality of reporting of randomized
controlled trials of herbal medicine interventions. Am J Med. 2006 Sep;119(9):800.e1-11.
(Collaborator)
93.
Gagnier J, Boon H, Rochon PA, Barnes J, Moher D, Bombardier C. Reporting Random
Controlled Trials of Herbal Medicines. Explore (NY). 2006 Mar;2(2):143-149.
94.
Judge J, Field TS, DeFlorio M, Laprino J, Auger J, Rochon PA, Bates DW, Gurwitz JH.
Prescribers’ Responses to Alerts During Medication Ordering in the Long Term Care Setting. J
Am Med Inform Assoc. 2006 Jul-Aug;13(4)385-90
95.
Dhalla IA, Mamdani MM, Simor AE, Kopp A, Rochon PA, Juurlink DN. Are broad spectrum
fluoroquinolones more likely to cause clostridium difficile-associated disease? Antimicrobial
Agents and Chemotherapy. Antimicrobial Agents and Chemotherapy. 2006 September;
50(9):3216-3219
96.
Marras C, Kopp A, Qui F, Lang AE, Sykora K, Shulman KI, Rochon PA. Antipsychotic use in
older adults with Parkinson’s disease. Movement Disorders Vol 22, No. 3, 2007, pp. 319-323.
97.
Reddy M, Gill SS, Rochon PA. Preventing Pressure Ulcers: A Systematic Review. (Aug 23-30)
JAMA. 2006;296:974-984. Selected for abstraction in Evidence Based Nursing, a BMJ quarterly.
98.
Lee PE, Gill SS, Rochon PA Atypical antipsychotics to treat the neuropsychiatric symptoms of
dementia. Neuropsychiatric Disease and Treatment 2006;2(4):521-29.
99.
Gagnier JJ, Boon H, Rochon PA, Moher D, Barnes J, Bombardier C. Recommendations for
reporting randomized controlled trials of herbal interventions: explanation and elaboration. J Clin
Epidemiol. 2006 Nov;59(11):1134-49.
100. Klein-Geltink JE, Rochon PA, Dyer S, Laxer MS, Anderson GM. Reader’s guide to critical
appraisal of cohort studies: An application to administrative data-based drug cohort studies. J Clin
Epidemiol. 2007;60(8):766-772.
101. Rochon PA, Stukel T, Bronskill SE, Gomes T, Sykora K, Wodchis W, Hillmer M, Kopp A, Gurwitz
J, Anderson G. Variation in Nursing Home Antipsychotic Prescribing Rates. Archives of Internal
Medicine 2007;167(7):676-683.
102. Lee PE, Rochon PA. Daily oral vitamin B-12 with or without folic acid for 24 weeks did not
improve cognitive function in elderly people. Evidence Based Medicine 2007 Feb:12(1):18.
February 15, 2016
7
CURRICULUM VITAE
Paula A. Rochon, MD, MPH, FRCPC
103. Ganjavi H, Lanctôt KL, Herrmann, N, Rochon PA, Sharma P, Lee M, Cassel D, Freedman M,
Black SE. Adverse drug events among elderly patients attending a memory clinic. Dementia and
Geriatric Cognitive Disorders 2007;23(6):395-400.
104. Gill SS, Bronskill SE, Normand SLT, Anderson GM, Sykora K, Lam K, Bell C, Lee PE, Fischer H,
Herrmann N, Gurwitz J, Rochon PA. Antipsychotic Drug Use and Mortality Among Older Adults
With Dementia: A Population-Based, Matched Cohort Study. Annals of Internal Medicine 2007
Jun 5;146(11):775-86.
Summary for patients in: Ann Intern Med. 2007 Jun 5;146(11):I52.
105. Herrmann N, Gill SS, Bell C, Anderson GM, Bronskill SE, Shulman KI, Fischer H, Sykora K, Shi
HS, Rochon PA. A population-based study of cholinesterase inhibitor prescribing for Alzheimer’s
disease: opportunities for improvement. Journal of the American Geriatrics Society [in press]
106. Bell C, Fischer HD, Gill SS, Zagorski B, Sykora K, Wodchis W, Herrmann N, Bronskill SE, Lee
PE, Anderson GM, Rochon PA. Initiation of benzodiazepines in the elderly after hospitalization:
retrospective cohort study. Journal of General Internal Medicine 2007;22(7):1024-1029.
107. Ganjavi H, Herrmann, N, Rochon PA, Sharma P, Lee M, Cassel D, Freedman M, Black SE,
Lanctôt. Adverse Drug Events in Cognitively Impaired Elderly Patients. Dementia and Geriatric
Cognitive Disorders 2007;23:295-300.
Peer-reviewed Letters, Editorials and Commentaries
1.
Rochon PA, Gurwitz JH, Cheung CM, Chalmers TC. Too Many Words? Mozart 1, Emperor 0.
JAMA. 1995;273(14):1087 (letter). (Principal Author).
2.
Rochon PA, Gurwitz JH. Prescribing for Elderly Persons. JAMA 2000;283:339-340 (letter).
(Principal Author).
3.
Neglia AM, Rochon PA. General Medical journals should have covered war in Kosovo more. BMJ
2000;321:1084. (letter). (Senior Responsible Author).
4.
Rochon PA, Bronskill S, Gurwitz JH. Health care for older people. BMJ 2002;324:1231-32
[editorial]. (Principal Author)
5.
Gill SS, Rochon PA, Guttman M, Laupacis A. Response Letter to Dr. Cummings Commentary on
The value of positron emission tomography in the clinical evaluation of dementia. Journal of the
American Geriatrics Society. 2003;51:258-264. J Am Geriatr Soc 2004; 52(3):468-9. (Collaborator)
6.
Gill SS, Mamdani M, Rochon PA. Management of Overactive Bladder. Letter – New England
Journal of Medicine 2004; 350(21): 2213. (Senior Responsible Author)
7.
Gill SS, Rochon PA. Review: Donepezil improves cognitive and functional outcomes in vascular
cognitive impairment. (American College of Physicians) ACP Journal Club 2004 Sep-Oct;
141(2):39. (Senior Responsible Author)
8.
Rochon PA, Mashari A, Cohen A, Misra A, Laxer D, Streiner DL, Dergal JM, Clark JP, Binns MA.
Response to Rebuttal: “Catering to the customers” - Louis B. Jacques on “The relation between
randomized control trials published in leading general medical journals and the global burden of
disease” (CMAJ) May 25, 2004; 170(11): 1673-77. CMAJ Nov 9, 2004;171(10):1150-51 (letter).
(Principal Author)
9.
Juurlink D, Mamdani M, Rochon PA, Kopp A, Shulman K, Redelmeier D. Loop diuretics and
angiotensin-converting enzyme inhibitors increased risk for hospitalization for lithium toxicity. ACP
Journal Club, January/February 2005, Vol 142, Number 1, Page 25. (Collaborator)
February 15, 2016
8
CURRICULUM VITAE
Paula A. Rochon, MD, MPH, FRCPC
10. Gold J, Rochon PA. Response to letter: Peer review of articles on global burden of disease. Ana
Marušić, Darko Hren, Matko Marušić. Croatian Medical Journal. CMAJ – Mar 2005;172(6):727-8.
(Senior Responsible Author)
11. Rochon PA, Lee PE. Citalopram did not differ from placebo for treatment of depression in patients
75 years of age. (Commentary on Roose T paper.) ACP J Club. 2005 May-Jun;142(3):79.
(Principal Author)
12. Gill SS, Rochon PA. Risk for injury in the elderly may vary by benzodiazepine, independent of
half-life. (Commentary on Tamblyn R paper J Am Geriatr Soc. 2005;53:233-41.) ACP J Club.
2005 Jul-Aug;143(1):24. (Senior Responsible Author)
13. Gold JL, Rochon PA. Using Technology to Reduce Adverse Drug Events in Elderly Long Term
Care Patients: The Case for Computerized Physician Order Entry. (Editorial) Aging Health
2005;1(2). (Senior Responsible Author)
14. Gill SS, Seitz D, Rochon PA. Atypical Antipsychotic Drugs, Dementia, and Risk of Death. JAMA,
February 1, 2006;295(5):495-6 (Senior Responsible Author)
Peer-reviewed Group Publications
1. Patterson CJS, Gauthier S, Bergman H, Cohen C, Freightner JW, Felman H, Hogan DB.
Management of Dementing Disorders. Conclusions from the Canadian Consensus Conference of
Dementia. Canadian Medical Association Journal. 1999;160:12 (suppl. 1).
Electronic Publications in Peer-reviewed Journals
1. Neglia MN, Rochon PA. Social Ills and Medicine: The Kosovo Crisis. British Medical Journal.
2000;320 (May 30).
February 15, 2016
9